ArticleOncoimmunology2016

Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival.

Sabrina Genßler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.